Cost-benefit analysis of the National Immunization Program in Spain.

Saved in:
Bibliographic Details
Title: Cost-benefit analysis of the National Immunization Program in Spain.
Authors: Pérez A; Management, Hospital Nuestra Señora De Sonsoles (Complejo Asistencial De Avila), Ávila, Spain., Fernández Prada M; Preventive Medicine and Public Health, Hospital Vital Alvarez Buylla, Asturias, Spain., Cassinello N; Financial and Accounting Management, Universidad Pontificia Comillas, Madrid, Spain., Vallejo-Aparicio LA; Market Access, GSK, Madrid, Spain., García A; Market Access, GSK, Madrid, Spain., González A; Health Economics and Market Access, Vivactis Weber, Madrid, Spain., Durán A; Health Economics and Market Access, Vivactis Weber, Madrid, Spain., Zozaya N; Health Economics and Market Access, Vivactis Weber, Madrid, Spain., Fernández I; Health Economics and Market Access, Vivactis Weber, Madrid, Spain., Daheron M; Health Economics and Market Access, Vivactis Weber, Madrid, Spain., Hidalgo Á; Weber Foundation, Madrid, Spain.; University of Castilla La Mancha, Toledo, Spain., Beck E; Value Evidence and Outcomes, GSK, Wavre, Belgium., García Ruiz A; IBIMA Platform Bionand, Universidad de Málaga - IBIMA Platform Bionand, Málaga, Spain.
Source: Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2385175. Date of Electronic Publication: 2024 Aug 19.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101572652 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2164-554X (Electronic) Linking ISSN: 21645515 NLM ISO Abbreviation: Hum Vaccin Immunother Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2164-554X
DOI:10.1080/21645515.2024.2385175